Integra LifeSciences Holdings Corporation (IART) NASDAQ
17.90
+0.96(+5.67%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
17.90
+0.96(+5.67%)
Currency In USD
| Previous Close | 16.94 |
| Open | 17.2 |
| Day High | 18.05 |
| Day Low | 17.08 |
| 52-Week High | 18.05 |
| 52-Week Low | 8.7 |
| Volume | 775,532 |
| Average Volume | 972,882 |
| Market Cap | 1.39B |
| PE | -2.77 |
| EPS | -6.47 |
| Moving Average 50 Days | 12.56 |
| Moving Average 200 Days | 12.67 |
| Change | 0.96 |
Integra LifeSciences Announces Key Executive Leadership Appointments
GlobeNewswire Inc.
Feb 17, 2026 1:30 PM GMT
Executive team further strengthened with appointments of Teshtar Elavia to the newly created chief technology officer role, Michael Hutchinson as chief legal officer, and Kerri DiPietro as chief quality officer, representing decades of experience in
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026
GlobeNewswire Inc.
Feb 09, 2026 11:35 AM GMT
PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 202
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 05, 2026 9:31 PM GMT
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knigh